Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

NCT04119674 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Drug is Anlotinib.
DRUG: Drug is Temozolomide Capsule.
RADIATION: Radiotherapy was initiated 4 to 6 weeks postoperatively.

Sponsor

Zhejiang Cancer Hospital